Online citations, reference lists, and bibliographies.
← Back to Search

Expression Of Laminin α1, α2, α4, And α5 Chains, Fibronectin, And Tenascin-C In Skeletal Muscle Of Dystrophic 129ReJdy/dyMice

B. Ringelmann, C. Röder, R. Hallmann, M. Maley, M. Davies, M. Grounds, L. Sorokin
Published 1999 · Biology

Cite This
Download PDF
Analyze on Scholarcy
Abstract Thedy/dymouse is an animal model for human merosin-negative congenital muscular dystrophy (CMD), which has been reported to have reduced or no expression of the basement membrane protein laminin α2. We here investigate various myogenic and nonmyogenic tissues of maturedy/dyand control 129ReJ mice histologically and for laminin α2 expression. In addition, expression patterns of laminin α1, α2, α4, and α5 chains, the interstitial proteins fibronectin and tenascin-C, and the adhesion molecules VCAM-1, ICAM-1, and α4 integrin were characterized in skeletal muscle of 1- and 7-day and mature (>6 weeks old)dy/dyand control 129ReJ mice. The laminin α2 chain remained detectable in myogenic tissues ofdy/dymice by immunofluorescence using two different monoclonal antibodies and by Northern blot analysis. However, laminin α2 expression was significantly reduced or not detectable in nonmyogenic tissues ofdy/dymice, including skin, lung, kidney, brain, thymus, and eye. Focal lesions were observed in mature skeletal muscle only, characterized by necrotic tissue, isolated VCAM-1- and ICAM-1-positive cells indicative of inflammatory processes, and regenerating muscle fibers surrounded by intense tenascin-C and fibronectin expression. In contrast to studies on human CMD muscle, laminin α1 was not detectable in eitherdy/dyor control skeletal muscle using immunofluorescence or Northern blot analysis. Immunofluorescence localized laminin α4 to basement membranes of blood vessels, the endoneurium of the intramuscular nerves, and the neuromuscular junction in skeletal muscle of 1- and 7-day-olddy/dyand control mice. In mature muscle, laminin α4 expression shifted to the perineurium of intramuscular nerves in bothdy/dyand control mice. Furthermore, strong upregulation of laminin α4 in the basement membranes of blood vessels, the perineurium of intramuscular nerves, and of isolated regenerating muscle fibers in thedy/dymice was apparent. Investigation of 1-day-old animals revealed expression of laminin α5 in skeletal muscle fiber basement membranes ofdy/dybut not control animals. This difference betweendy/dyand control animals was no longer apparent at 7 days after birth, indicating a temporary shift in expression pattern of laminin α5 indy/dyanimals. Analysis of the extracellular matrix components of 1- and 7-day-olddy/dyand control skeletal muscle revealed an early onset of the dystrophy, even before histopathological features of the disease were evident. Our data confirm the absence of laminin α1 chain in myogenic tissues of bothdy/dyand control mice and suggest compensation for reduced laminin α2 indy/dyskeletal muscle by laminin α4 and, in early development, also laminin α5. These results have significant ramifications in the diagnosis of human merosin-negative CMD.
This paper references
Tenascin during gut development: appearance in the mesenchyme, shift in molecular forms, and dependence on epithelial-mesenchymal interactions [published erratum appears in J Cell Biol 1989 Mar;108(3):following 1175]
E. Aufderheide (1988)
Tenascin: an extracellular matrix protein involved in tissue interactions during fetal development and oncogenesis
R. Chiquetehrismann (1986)
Deficiency of merosin in dystrophic dy mice and genetic linkage of laminin M chain gene to dy locus.
Y. Sunada (1994)
Mild congenital muscular dystrophy in two patients with an internally deleted laminin alpha2-chain.
V. Allamand (1997)
Expression of laminin isoforms in mouse myogenic cells in vitro and in vivo.
F. Schuler (1995)
Laminin alters cell shape and stimulates motility and proliferation of murine skeletal myoblasts.
M. Ocalan (1988)
Cloning and expression of a cDNA encoding mouse endoglin, an endothelial cell TGF-β ligand
A. Ge (1994)
Recombinant expression and properties of the Kunitz-type protease-inhibitor module from human type VI collagen alpha 3(VI) chain.
U. Mayer (1994)
A. M. Michelson (1955)
Transient neonatal denervation alters the proliferative capacity of myosatellite cells in dystrophic (129ReJdy/dy) muscle.
M. Ontell (1992)
Selective immunoreactivities of kidney basement membranes to monoclonal antibodies against laminin: localization of the end of the long arm and the short arms to discrete microdomains
D. Abrahamson (1989)
Histopathology of hereditary, progressive muscular dystrophy in inbred strain 129 mice
W. T. West (1960)
Adhesion Receptors as Therapeutic Targets
M. Horton (1995)
Expression of laminin subunits in human fetal skeletal muscle
C. Sewry (2004)
Transient and locally restricted expression of laminin a chain mRNA by developing epithelial cells during kidney organogenesis
M. Ekblom (1990)
Defective muscle basement membrane and lack of M-laminin in the dystrophic dy/dy mouse.
H. Xu (1994)
Laminin α2 chain‐null mutant mice by targeted disruption of the Lama2 gene: a new model of merosin (laminin 2)‐deficient congenital muscular dystrophy
Y. Miyagoe (1997)
Molecular Cloning of a Novel Laminin Chain, α5, and Widespread Expression in Adult Mouse Tissues (*)
J. Miner (1995)
Receptors for laminins during epithelial morphogenesis.
P. Ekblom (1996)
Amino acid sequence of mouse tenascin and differential expression of two tenascin isoforms during embryogenesis
A. Weller (1991)
Tenascin-C expression correlates with macrophage invasion in Duchenne muscular dystrophy and in myositis
D. Gullberg (1997)
Roles for the integrin VLA-4 and its counter receptor VCAM-1 in myogenesis
G. Rosen (1992)
Expression of merosin in the thymus and its interaction with thymocytes.
A. Chang (1993)
Diagnosis of merosin (laminin-2) deficient congenital muscular dystrophy by skin biopsy
C. Sewry (1996)
The mouse; its reproduction and development
R. Rugh (1968)
Merosin, a protein specific for basement membranes of Schwann cells, striated muscle, and trophoblast, is expressed late in nerve and muscle development.
I. Leivo (1988)
Factors influencing the repair and adaptation of muscles in aged individuals: satellite cells and innervation.
B. Carlson (1995)
Vascular cell adhesion molecule-1: expression in normal and diseased skin and regulation in vivo by interferon gamma.
R. Groves (1993)
Congenital muscular dystrophies.
K. Arahata (1995)
Adhesion of human B cells to follicular dendritic cells involves both the lymphocyte function-associated antigen 1/intercellular adhesion molecule 1 and very late antigen 4/vascular cell adhesion molecule 1 pathways
G. Koopman (1991)
The Expression of Extracellular Matrix During Adult Skeletal Muscle Regeneration: How the Basement Membrane, Interstitium and Myogenic Cells Collaborate
M. Grounds (1998)
Merosin and laminin in myogenesis; specific requirement for merosin in myotube stability and survival
P. Vachon (1996)
Absence of trauma-induced leukocyte rolling in mice deficient in both P- selectin and intercellular adhesion molecule 1
E. Kunkel (1996)
Presence of Laminin α5 Chain and Lack of Laminin α1 Chain during Human Muscle Development and in Muscular Dystrophies*
Carl-Fredrik Tiger (1997)
Developmental regulation of the laminin alpha5 chain suggests a role in epithelial and endothelial cell maturation.
L. Sorokin (1997)
A VCAM-like adhesion molecule on murine bone marrow stromal cells mediates binding of lymphocyte precursors in culture
K. Miyake (1991)
Induction of tenascin in healing wounds
E. Mackie (1988)
Mouse heart laminin. Purification of the native protein and structural comparison with Engelbreth-Holm-Swarm tumor laminin.
M. Paulsson (1989)
8 – Structure and Function of Laminin
J. Engel (1993)
Laminin-nidogen complex. Extraction with chelating agents and structural characterization.
M. Paulsson (1987)
Modification of the phenotypic expression of murine dystrophy: A morphological study
D. Bourke (1986)
Expression of laminin subunits in congenital muscular dystrophy
C. Sewry (1995)
Abnormal localization of laminin subunits in muscular dystrophies
Y. Hayashi (1993)
Cloning of the Mouse Laminin α4 cDNA. Expression in a Subset of Endothelium
Michael Frieser (1997)
Merosin, a tissue-specific basement membrane protein, is a laminin-like protein.
K. Ehrig (1990)
Differential expression of laminin polypeptides in developing and adult human kidney.
I. Virtanen (1995)
Inhibition of mixed lymphocyte response by a rat monoclonal antibody to a novel murine lymphocyte activation antigen (MALA-2).
F. Takei (1985)
Differential expression of tenascin after denervation, damage or paralysis of mouse soleus muscle
A. Irintchev (1993)
Identification of a murine Peyer's patch—specific lymphocyte homing receptor as an integrin molecule with an α chain homologous to human VLA-4α
B. Holzmann (1989)
Abnormalities in Schwann cell sheaths in spinal nerve roots of dystrophic mice.
Stirling Ca (1975)
Mouse polymorphonuclear granulocyte binding to extracellular matrix molecules involves β1 integrins
M. Frieser (1996)
Pathophysiology of muscular dystrophy.
T. Partridge (1993)
The E8 subfragment of laminin promotes locomotion of myoblasts over extracellular matrix
S. Goodman (1989)
Myosin isoforms in hindlimb muscles of normal and dystrophic (ReJ129 dy/sol;dy) mice
C. Reggiani (1992)
Characterization of native laminin from bovine kidney and comparison with other laminin variants.
A. Lindblom (1994)
Molecular Cloning: A Laboratory Manual
J. Sambrook (1983)
Role of laminin and fibronectin in selecting myogenic versus fibrogenic cells from skeletal muscle cells in vitro.
U. Kuehl (1986)
Primary structure and expression of a novel human laminin α4 chain
A. Iivanainen (1995)
Absence of laminin α1 chain in the skeletal muscle of dystrophic dy/dy mice
Carl-Fredrik Tiger (1997)
Expression of laminin α1, α5 and β2 chains during embryogenesis of the kidney and vasculature
M. Durbeej (1996)
Distribution and Function of Laminins in the Neuromuscular System of Developing, Adult, and Mutant Mice
B. Patton (1997)
Monoclonal antibodies against laminin A chain fragment E3 and their effects on binding to cells and proteoglycan and on kidney development.
L. Sorokin (1992)
Age-related changes in replication of myogenic cells in mdx mice: Quantitative autoradiographic studies
J. Mcgeachie (1993)

This paper is referenced by
Alternative Splice Variants of α7β1Integrin Selectively Recognize Different Laminin Isoforms*
H. von der Mark (2002)
Muscle regeneration: molecular aspects and therapeutic implications.
M. Grounds (1999)
Distinct Roles for Laminin Globular Domains in Laminin α1 Chain Mediated Rescue of Murine Laminin α2 Chain Deficiency
K. Gawlik (2010)
Immunobiology and the future of myoblast transfer therapy.
G. Smythe (2000)
Loss of astrocyte polarization upon transient focal brain ischemia as a possible mechanism to counteract early edema formation
E. Steiner (2012)
Extracellular deposition of matrilin-2 controls the timing of the myogenic program during muscle regeneration
Ferenc Deák (2014)
Overexpression of alpha4 chain-containing laminins in human glial tumors identified by gene microarray analysis.
J. Ljubimova (2001)
Transcription Factors Providing Myogenic Identity to Adult Muscle Satellite Cells
Jeff Ishibashi (2007)
Endothelial basement membrane laminins as an environmental cue in monocyte differentiation to macrophages
L. Li (2020)
Isolated Anxa5+/Sca-1+ perivascular cells from mouse meningeal vasculature retain their perivascular phenotype in vitro and in vivo.
B. Brachvogel (2007)
Adeno-associated viral-mediated LARGE gene therapy rescues the muscular dystrophic phenotype in mouse models of dystroglycanopathy.
M. Yu (2013)
Overexpression of mini‐agrin in skeletal muscle increases muscle integrity and regenerative capacity in laminin‐α2‐deficient mice
C. Florian Bentzinger (2005)
Laminin alpha4 and integrin alpha6 are upregulated in regenerating dy/dy skeletal muscle: comparative expression of laminin and integrin isoforms in muscles regenerating after crush injury.
L. Sorokin (2000)
A single point mutation in the LN domain of LAMA2 causes muscular dystrophy and peripheral amyelination
B. Patton (2008)
Linker molecules between laminins and dystroglycan ameliorate laminin-α2–deficient muscular dystrophy at all disease stages
S. Meinen (2007)
Skeletal muscle laminin and MDC1A: pathogenesis and treatment strategies
K. Gawlik (2010)
Proteasome inhibition improves the muscle of laminin α2 chain-deficient mice.
V. Carmignac (2011)
Mechanical loading regulates the expression of tenascin-C in the myotendinous junction and tendon but does not induce de novo synthesis in the skeletal muscle
T. Järvinen (2003)
Recombinant Laminin-8 (α4β1γ1)
J. Kortesmaa (2000)
Leukaemia inhibitory factor increases myoblast replication and survival and affects extracellular matrix production: combined in vivo and in vitro studies in post-natal skeletal muscle
J. White (2001)
Genetic inactivation of the laminin alpha5 chain receptor Lu/BCAM leads to kidney and intestinal abnormalities in the mouse.
C. Rahuel (2008)
Laminins in blood vessel development and disease -functional aspects in angiogenesis, atherosclerosis, and muscular dystrophy
A. Nyström (2006)
Causal Varian discovery in Familial Congenital Heart Disease - An Integrative -Omic Approach
Wendy Demos (2012)
Molecular basis of muscular dystrophies
R. Cohn (2000)
Hanging on for the ride: adhesion to the extracellular matrix mediates cellular responses in skeletal muscle morphogenesis and disease.
M. Goody (2015)
Laminin α2 deficiency and muscular dystrophy; genotype-phenotype correlation in mutant mice
L. Guo (2003)
Annexin A5 Is Not Essential for Skeletal Development
B. Brachvogel (2003)
The trunk neural crest and its early glial derivatives: a study of survival responses, developmental schedules and autocrine mechanisms
A. Woodhoo (2004)
Inherited disorders of the extracellular matrix.
C. Sewry (1999)
A hypoxia complement differentiates the muscle response to endurance exercise
Silvia Schmutz (2010)
Cell Adhesion and Migration Properties of β2-Integrin Negative Polymorphonuclear Granulocytes on Defined Extracellular Matrix Molecules
M. Sixt (2001)
Impaired fetal muscle development and JAK-STAT activation mark disease onset and progression in a mouse model for merosin-deficient congenital muscular dystrophy
A. Nunes (2017)
See more
Semantic Scholar Logo Some data provided by SemanticScholar